Marc Besselink

About

Professor of Pancreatic and Hepatobiliary surgery at Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam

Employment

• Amsterdam UMC Professor of Pancreatic and Hepatobiliary (HPB) surgery
  2012 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (684)

• Antibiotic-associated Enterococcus expansion in the gastrointestinal tract precedes infected necrosis in acute necrotizing pancreatitis
  Gut Microbes 2026 DOI: 10.1080/19490976.2026.2670039
  +Save
• ASO Author Reflections: R0 Resection Should Not Be Dismissed in Node-Positive Pancreatic Ductal Adenocarcinoma
  Annals of Surgical Oncology 2026 DOI: 10.1245/s10434-026-20047-y
  +Save
• Development of an Environmental Impact Calculator for Minimally Invasive Cholecystectomy: Protocol and Methodological Framework of the ECOMIS Project
  Healthcare 2026 DOI: 10.3390/healthcare14213622
  +Save
• Impact of R0/R1 Margin Status on Overall Survival in Node-Positive Resected Pancreatic Ductal Adenocarcinoma: Meta-Analysis
  Annals of Surgical Oncology 2026 DOI: 10.1245/s10434-026-19850-4
  +Save
• Splenic hilum nodal involvement in resected left-sided pancreatic cancer: meta-analysis
  BJS Open 2026 DOI: 10.1093/bjsopen/zrag153
  +Save
• Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study
  Pain 2026 DOI: 10.1097/j.pain.0000000000004059
  +Save
• Hospital costs associated with complications following pancreatoduodenectomy: systematic review
  BJS Open 2026 DOI: 10.1093/bjsopen/zrag055
  +Save
• Implications and risk of new versus persisting intraductal papillary mucinous neoplasms after pancreatic surgery: meta-analysis
  BJS Open 2026 DOI: 10.1093/bjsopen/zrag087
  +Save
• Therapeutic strategies and outcomes in the management of ampullary tumours: meta-analysis
  BJS Open 2026 DOI: 10.1093/bjsopen/zrag115
  +Save
• Figure S1 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
  2026 DOI: 10.1158/2326-6066.32703127
  +Save
• Figure S10 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
  2026 DOI: 10.1158/2326-6066.32703121
  +Save
• Figure S11 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
  2026 DOI: 10.1158/2326-6066.32703118
  +Save
• Figure S12 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
  2026 DOI: 10.1158/2326-6066.32703112
  +Save
• Figure S13 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
  2026 DOI: 10.1158/2326-6066.32703109
  +Save
• Figure S14 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
  2026 DOI: 10.1158/2326-6066.32703103
  +Save
• Figure S15 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
  2026 DOI: 10.1158/2326-6066.32703097
  +Save
• Figure S16 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
  2026 DOI: 10.1158/2326-6066.32703091
  +Save
• Figure S2 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
  2026 DOI: 10.1158/2326-6066.32703088
  +Save
• Figure S3 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
  2026 DOI: 10.1158/2326-6066.32703082
  +Save
• Figure S4 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
  2026 DOI: 10.1158/2326-6066.32703079
  +Save